Literature DB >> 32325086

Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.

Bettina Kunze1, Frederik Wein1, Hsin-Yu Fang1, Akanksha Anand1, Theresa Baumeister1, Julia Strangmann1, Sophie Gerland1, Jonas Ingermann1, Natasha Stephens Münch1, Maria Wiethaler1, Vincenz Sahm1, Ana Hidalgo-Sastre1, Sebastian Lange1, Charles J Lightdale2, Aqiba Bokhari3, Gary W Falk4, Richard A Friedman5, Gregory G Ginsberg4, Prasad G Iyer6, Zhezhen Jin7, Hiroshi Nakagawa8, Carrie J Shawber9, TheAnh Nguyen10, William J Raab11, Piero Dalerba12, Anil K Rustgi8, Antonia R Sepulveda11, Kenneth K Wang6, Roland M Schmid1, Timothy C Wang8, Julian A Abrams13, Michael Quante14.   

Abstract

BACKGROUND & AIMS: Studies are needed to determine the mechanism by which Barrett's esophagus (BE) progresses to esophageal adenocarcinoma (EAC). Notch signaling maintains stem cells in the gastrointestinal tract and is dysregulated during carcinogenesis. We explored the relationship between Notch signaling and goblet cell maturation, a feature of BE, during EAC pathogenesis.
METHODS: We measured goblet cell density and levels of Notch messenger RNAs in BE tissues from 164 patients, with and without dysplasia or EAC, enrolled in a multicenter study. We analyzed the effects of conditional expression of an activated form of NOTCH2 (pL2.Lgr5.N2IC), conditional deletion of NOTCH2 (pL2.Lgr5.N2fl/fl), or loss of nuclear factor κB (NF-κB) (pL2.Lgr5.p65fl/fl), in Lgr5+ (progenitor) cells in L2-IL1B mice (which overexpress interleukin 1 beta in esophagus and squamous forestomach and are used as a model of BE). We collected esophageal and stomach tissues and performed histology, immunohistochemistry, flow cytometry, transcriptome, and real-time polymerase chain reaction analyses. Cardia and forestomach tissues from mice were cultured as organoids and incubated with inhibitors of Notch or NF-kB.
RESULTS: Progression of BE to EAC was associated with a significant reduction in goblet cell density comparing nondysplastic regions of tissues from patients; there was an inverse correlation between goblet cell density and levels of NOTCH3 and JAG2 messenger RNA. In mice, expression of the activated intracellular form of NOTCH2 in Lgr5+ cells reduced goblet-like cell maturation, increased crypt fission, and accelerated the development of tumors in the squamocolumnar junction. Mice with deletion of NOTCH2 from Lgr5+ cells had increased maturation of goblet-like cells, reduced crypt fission, and developed fewer tumors. Esophageal tissues from in pL2.Lgr5.N2IC mice had increased levels of RelA (which encodes the p65 unit of NF-κB) compared to tissues from L2-IL1B mice, and we found evidence of increased NF-κB activity in Lgr5+ cells. Esophageal tissues from pL2.Lgr5.p65fl/fl mice had lower inflammation and metaplasia scores than pL2.Lgr5.N2IC mice. In organoids derived from pL2-IL1B mice, the NF-κB inhibitor JSH-23 reduced cell survival and proliferation.
CONCLUSIONS: Notch signaling contributes to activation of NF-κB and regulates differentiation of gastric cardia progenitor cells in a mouse model of BE. In human esophageal tissues, progression of BE to EAC was associated with reduced goblet cell density and increased levels of Notch expression. Strategies to block this pathway might be developed to prevent EAC in patients with BE.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett’s Esophagus; Carcinogenesis; Esophageal Adenocarcinoma; Goblet Cells

Mesh:

Substances:

Year:  2020        PMID: 32325086      PMCID: PMC7484392          DOI: 10.1053/j.gastro.2020.04.033

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

1.  Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.

Authors:  Yuji Tamagawa; Norihisa Ishimura; Goichi Uno; Takafumi Yuki; Hideaki Kazumori; Shunji Ishihara; Yuji Amano; Yoshikazu Kinoshita
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

2.  Aberrant expression of Wnt and Notch signal pathways in Barrett's esophagus.

Authors:  Xia Chen; Ke Jiang; Zhining Fan; Zheng Liu; Ping Zhang; Liduan Zheng; Na Peng; Jingjing Tong; Guozhong Ji
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-08-11       Impact factor: 2.947

3.  Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.

Authors:  Xiaohong Li; Thomas G Paulson; Patricia C Galipeau; Carissa A Sanchez; Karen Liu; Mary K Kuhner; Carlo C Maley; Steven G Self; Thomas L Vaughan; Brian J Reid; Patricia L Blount
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

4.  Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.

Authors:  Guangchun Jin; Vigneshwaran Ramanathan; Michael Quante; Gwang Ho Baik; Xiangdong Yang; Sophie S W Wang; Shuiping Tu; Shanisha A K Gordon; David Mark Pritchard; Andrea Varro; Arthur Shulkes; Timothy C Wang
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

5.  Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.

Authors:  Tarek Sawas; Sarah Killcoyne; Prasad G Iyer; Kenneth K Wang; Thomas C Smyrk; John B Kisiel; Yi Qin; David A Ahlquist; Anil K Rustgi; Rui J Costa; Moritz Gerstung; Rebecca C Fitzgerald; David A Katzka
Journal:  Gastroenterology       Date:  2018-08-27       Impact factor: 22.682

6.  Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation.

Authors:  Valerie Besseyrias; Emma Fiorini; Lothar J Strobl; Ursula Zimber-Strobl; Alexis Dumortier; Ute Koch; Marie-Laure Arcangeli; Sophie Ezine; H Robson Macdonald; Freddy Radtke
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

7.  Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.

Authors:  Katia Nones; Nicola Waddell; Nicci Wayte; Ann-Marie Patch; Peter Bailey; Felicity Newell; Oliver Holmes; J Lynn Fink; Michael C J Quinn; Yue Hang Tang; Guy Lampe; Kelly Quek; Kelly A Loffler; Suzanne Manning; Senel Idrisoglu; David Miller; Qinying Xu; Nick Waddell; Peter J Wilson; Timothy J C Bruxner; Angelika N Christ; Ivon Harliwong; Craig Nourse; Ehsan Nourbakhsh; Matthew Anderson; Stephen Kazakoff; Conrad Leonard; Scott Wood; Peter T Simpson; Lynne E Reid; Lutz Krause; Damian J Hussey; David I Watson; Reginald V Lord; Derek Nancarrow; Wayne A Phillips; David Gotley; B Mark Smithers; David C Whiteman; Nicholas K Hayward; Peter J Campbell; John V Pearson; Sean M Grimmond; Andrew P Barbour
Journal:  Nat Commun       Date:  2014-10-29       Impact factor: 14.919

8.  Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.

Authors:  Zhen-Shu Xu; Ju-Shun Zhang; Jing-Yan Zhang; Shun-Quan Wu; Dong-Lian Xiong; Hui-Jun Chen; Zhi-Zhe Chen; Rong Zhan
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

Review 9.  Notch as a Driver of Gastric Epithelial Cell Proliferation.

Authors:  Elise S Demitrack; Linda C Samuelson
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-02-14

10.  High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.

Authors:  Amitabh Srivastava; Kevin L Golden; Carissa A Sanchez; Karen Liu; Pui Yee Fong; Xiaohong Li; David S Cowan; Peter S Rabinovitch; Brian J Reid; Patricia L Blount; Robert D Odze
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more
  23 in total

1.  Another Notch in the mechanism of Barrett oesophagus progression.

Authors:  Iain Dickson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07       Impact factor: 46.802

Review 2.  Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's Esophagus.

Authors:  Nicola F Frei; Matthew D Stachler
Journal:  Visc Med       Date:  2022-02-02

Review 3.  Mechanisms and pathophysiology of Barrett oesophagus.

Authors:  Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-07       Impact factor: 73.082

4.  Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus.

Authors:  Julian A Abrams; Armando Del Portillo; Caitlin Hills; Griselda Compres; Richard A Friedman; Bin Cheng; John Poneros; Charles J Lightdale; Rachel De La Rue; Massimiliano di Pietro; Rebecca C Fitzgerald; Antonia Sepulveda; Timothy C Wang
Journal:  Cancer Prev Res (Phila)       Date:  2021-03-29

Review 5.  Understanding the cellular origin and progression of esophageal cancer using esophageal organoids.

Authors:  Uma M Sachdeva; Masataka Shimonosono; Samuel Flashner; Ricardo Cruz-Acuña; Joel T Gabre; Hiroshi Nakagawa
Journal:  Cancer Lett       Date:  2021-04-07       Impact factor: 9.756

6.  Notch signaling drives development of Barrett's metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa.

Authors:  Bettina Kunze; Moritz Middelhoff; H Carlo Maurer; Tatiana Agibalova; Akanksha Anand; Anne-Marie Bührer; Hsin-Yu Fang; Theresa Baumeister; Katja Steiger; Julia Strangmann; Roland M Schmid; Timothy C Wang; Michael Quante
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

Review 7.  Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment.

Authors:  Siyuan Luan; Xiaoxi Zeng; Chao Zhang; Jiajun Qiu; Yushang Yang; Chengyi Mao; Xin Xiao; Jianfeng Zhou; Yonggang Zhang; Yong Yuan
Journal:  Front Cell Dev Biol       Date:  2021-03-19

8.  Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival.

Authors:  Nathaniel Weygant; Karen Chang; Christian S Jackson; Kenneth J Vega
Journal:  Clin Transl Gastroenterol       Date:  2020-12-18       Impact factor: 4.488

Review 9.  Stem cells and origins of cancer in the upper gastrointestinal tract.

Authors:  Yoku Hayakawa; Hiroshi Nakagawa; Anil K Rustgi; Jianwen Que; Timothy C Wang
Journal:  Cell Stem Cell       Date:  2021-06-14       Impact factor: 25.269

10.  High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett's Esophagus.

Authors:  Andrea Proaño-Vasco; Theresa Baumeister; Amira Metwaly; Sandra Reitmeier; Karin Kleigrewe; Chen Meng; Michael Gigl; Thomas Engleitner; Rupert Öllinger; Roland Rad; Katja Steiger; Akanksha Anand; Julia Strangmann; Robert Thimme; Roland M Schmid; Timothy C Wang; Michael Quante
Journal:  Microorganisms       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.